Peptris

Accelerating drug discovery by using AI to make better decisions early, leading to faster, cheaper, and more reliable drug development.

Peptris

Company

2019

Founded

Life Sciences

Category

Peptris uses an AI-powered platform to computationally optimize and prioritize novel and repurposed drug candidates. This is done by predicting molecular interactions, safety, and various properties before wet-lab testing. By focusing on making higher-quality decisions at the earliest stages of discovery - the platform cuts development timelines and costs while improving success rates across rare diseases, oncology, and inflammation, enabling faster translation of promising science into viable therapies.